Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1341 (LINC01341)
- Target
- LINC01341
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01
Overview
Long intergenic non-protein coding RNA 1341 (LINC01341) is a putative long intergenic non-coding RNA, based on naming conventions used for lincRNAs. The molecule has not been characterized in the literature. Its molecular class indicates it is likely involved in epigenetic regulatory functions, similar to other lincRNAs, but there are no established data on its biological activity, disease relevance, or druggability. Notably, a closely related molecule, LINC00341, is well-studied and is implicated as a prognostic marker for cancer and a suppressor of metastasis through epigenetic mechanisms, but no such information exists for LINC01341[2]. Therefore, the name may be incorrectly cited in place of LINC00341, as LINC01341 is absent from primary research and genomic databases.
02
Mechanism of action
Not established. No drugs are known to interact with LINC01341, and thus no mechanisms are described for it.
03
Biological functions
Gene regulationEpigenetic regulationChromatin modification (as with other lincRNAs)Possible transcriptional regulation or involvement in cellular signaling, inferred from lincRNA class functions
04
Disease associations
Not established for LINC01341. No current evidence links this specific molecule to disease roles. (Caution: LINC00341, a different molecule, is associated with cancer prognosis and metastasis)
05
Safety considerations
None are reported or known for LINC01341 due to lack of evidence on its function or drug interaction.
06
Interacting drugs
None known; no drugs are reported to target LINC01341. For lincRNAs generally, there may be experimental modulation with epigenetic agents, but this is not described for LINC01341 specifically.
07
Biomarkers
No evidence for use of LINC01341 as a biomarker.
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1341 (LINC01341).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1341 (LINC01341).